Hypoglycemic Agents: all 3,927 studies that test it

Page 8 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)CompletedNCT02059161Phase 3Results posted
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT02058160Phase 3Results posted
• Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCompletedNCT02049814Phase 4Results posted
• Use of Sitagliptin to Decrease MicroalbuminuriaTerminatedNCT02048904Phase 4Results posted
• Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical PatientsCompletedNCT02035787Phase 2Results posted
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesCompletedNCT02034513Phase 3Results posted
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesCompletedNCT02030600Phase 3Results posted
• Intranasal Insulin for Weight Management During Smoking CessationCompletedNCT02028871Phase 2Results posted
• Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate TabletsCompletedNCT02028767Phase 1Results posted
• Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer RiskCompletedNCT02028221Phase 2Results posted
• Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)TerminatedNCT02019979Phase 2Results posted
• Januvia (Sitagliptin) in Healing Chronic Diabetic Foot UlcersTerminatedNCT02015910Phase 4Results posted
• Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and GlimepirideCompletedNCT02007278Phase 4Results posted
• Glycemic Responses to Majia Pomelos in Type 2 Diabetic PatientsCompletedNCT02006836Not applicableResults posted
• Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosisCompletedNCT02006342Not applicableResults posted
• Linagliptin Inpatient TrialCompletedNCT02004366Phase 4Results posted
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM PatientsCompletedNCT02002221Phase 4Results posted
• A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 DiabetesCompletedNCT01999322Phase 3Results posted
• Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single TabletsCompletedNCT01975220Phase 1Results posted
• Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyCompletedNCT01972724Phase 4Results posted
• Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac SurgeryTerminatedNCT01970462Phase 4Results posted
• Inpatient Diabetes on CorticosteroidsCompletedNCT01970241Phase 4Results posted
• The Effect of Linagliptin on Mitochondrial and Endothelial FunctionCompletedNCT01969084Phase 4Results posted
• Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial AdenocarcinomaCompletedNCT01968317Phase 2Results posted
• Effect of Insulin Sensitizer Metformin on AD BiomarkersCompletedNCT01965756Phase 2Results posted
• Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver DiseaseCompletedNCT01963845Phase 2Results posted
• Comparison of Insulin Therapy in Treating Post-Transplant DiabetesTerminatedNCT01963728Phase 4Results posted
• Effect of Exenatide on Liver and Heart Fat and InflammationCompletedNCT01951651Phase 4Results posted
• Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01951339Not applicableResults posted
• Study of Human Non-Shivering Thermogenesis and Basal Metabolic RateCompletedNCT01950520Phase 2Results posted
• Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.CompletedNCT01947153Phase 1Results posted
• Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DCompletedNCT01937598Phase 3Results posted
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetTerminatedNCT01931566Phase 3Results posted
• Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking MetforminCompletedNCT01929863Phase 2Results posted
• Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney TransplantCompletedNCT01928199Phase 4Results posted
• Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic PatientsTerminatedNCT01910441Phase 4Results posted
• Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and MetforminCompletedNCT01907854Phase 4Results posted
• Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast CancerActive, not recruitingNCT01905046Phase 3Results posted
• Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery DiseaseTerminatedNCT01901224Phase 4Results posted
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)CompletedNCT01897532Phase 4Results posted
• Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes MellitusCompletedNCT01892020Phase 4Results posted
• Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 DiabetesCompletedNCT01890122Phase 3Results posted
• Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01889667Phase 2Results posted
• Characterizing and Predicting Drug Effects on CognitionCompletedNCT01889602Phase 4Results posted
• Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 DiabetesCompletedNCT01882907Phase 4Results posted
• Metformin Therapy for Overweight Adolescents With Type 1 DiabetesCompletedNCT01881828Phase 3Results posted
• Effect of Chronic Incretin-based Therapy in Cystic FibrosisCompletedNCT01879228Not applicableResults posted
• A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic WomenCompletedNCT01877564Phase 2Results posted
• Metformin at the Cellular Level and Dosing for Diabetes Mellitus (DM)TerminatedNCT01876992Not applicableResults posted
• Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast MediaCompletedNCT01873859Not applicableResults posted
• Vildagliptin/Metformin in T2DM Patients Starting Basal InsulinCompletedNCT01871558Phase 3Results posted
• A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)CompletedNCT01868542Phase 4Results posted
• Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 DiabetesCompletedNCT01864174Phase 4Results posted
• Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin TherapyCompletedNCT01859793Phase 4Results posted
• Topiramate in Adolescents With Severe ObesityCompletedNCT01859013Phase 2Results posted
• Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DMCompletedNCT01855243Not applicableResults posted
• A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01849289Phase 3Results posted
• Metformin+Cytarabine for the Treatment of Relapsed/Refractory AMLTerminatedNCT01849276Phase 1Results posted
• Sitagliptin Therapy in Hospitalized Patients With Type 2 DiabetesCompletedNCT01845831Phase 4Results posted
• Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single TabletsCompletedNCT01845077Phase 1Results posted
• Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single TabletsCompletedNCT01844531Phase 1Results posted
• OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.CompletedNCT01842620Phase 4Results posted
• Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedNCT01841359Phase 4Results posted
• A Phase II Study of Pioglitazone for Patients With Cancer of the PancreasCompletedNCT01838317Phase 2Results posted
• Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in PregnancyCompletedNCT01837680Not applicableResults posted
• A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01835431Phase 3Results posted
• Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)CompletedNCT01825798Phase 3Results posted
• Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 DiabetesCompletedNCT01822548Phase 3Results posted
• Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 WeeksCompletedNCT01819272Phase 2Results posted
• A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice DailyCompletedNCT01814137Phase 3Results posted
• Effect of Metformin on Vascular and Mitochondrial Function in Type 1 DiabetesCompletedNCT01813929Phase 4Results posted
• Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered TogetherCompletedNCT01811953Phase 1Results posted
• Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine DependenceCompletedNCT01811940Phase 2/3Results posted
• The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized PatientsCompletedNCT01810952Phase 4Results posted
• A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseCompletedNCT01809327Phase 3Results posted
• EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 DiabetesCompletedNCT01808690Phase 3Results posted
• Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DMCompletedNCT01804842Phase 1/2Results posted
• Metformin and Muscle in Insulin-resistant Older VeteransCompletedNCT01804049Phase 1/2Results posted
• Continuous Treatment Study of Topiramate in Migraine ParticipantsCompletedNCT01799590Phase 2Results posted
• A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial CarcinomaCompletedNCT01797523Phase 2Results posted
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedNCT01794143Phase 3Results posted
• Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) PatientsCompletedNCT01792830Phase 3Results posted
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptinCompletedNCT01792518Phase 3Results posted
• Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's DiseaseTerminatedNCT01789047Phase 2Results posted
• Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence SyndromeCompletedNCT01781234Phase 2Results posted
• RISE Pediatric Medication StudyCompletedNCT01779375Phase 3Results posted
• RISE Adult Medication StudyCompletedNCT01779362Phase 3Results posted
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 DiabetesCompletedNCT01778049Phase 3Results posted
• A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01777282Phase 3Results posted
• The Health Influences of Puberty (HIP) StudyCompletedNCT01775813Phase 4Results posted
• The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)CompletedNCT01767909Phase 2/3Results posted
• Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by MetforminCompletedNCT01766778Phase 4Results posted
• Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic EncephalopathyTerminatedNCT01765218Phase 1/2Results posted
• Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy DrinkersTerminatedNCT01764685Phase 2Results posted
• Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in HumansCompletedNCT01762046Phase 1Results posted
• A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)CompletedNCT01760447Phase 3Results posted
• A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin IntoleranceCompletedNCT01751984Phase 2Results posted
• A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLLCompletedNCT01750567Phase 2Results posted
• Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBICompletedNCT01750268Phase 4Results posted
• A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSDCompletedNCT01749215Phase 4Results posted

← Hypoglycemic Agents overview